These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30121590)

  • 1. Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia.
    Li A; Ji S; Yue W; Yan H; Dong F; Ruan C; Li W; Lu W; Zhang D; Wang C
    BMJ Open; 2018 Aug; 8(8):e020070. PubMed ID: 30121590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis.
    Yin A; Shang D; Wen Y; Li L; Zhou T; Lu W
    Eur J Clin Pharmacol; 2016 Aug; 72(8):933-44. PubMed ID: 27117554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics of Olanzapine and Samidorphan When Administered in Combination in Healthy Subjects and Patients With Schizophrenia.
    Sun L; Mills R; Sadler BM; Rege B
    J Clin Pharmacol; 2021 Nov; 61(11):1430-1441. PubMed ID: 34018607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Smoking, Sex, Infection, and Comedication Administration on Oral Olanzapine: A Population Pharmacokinetic Model in Chinese Psychiatric Patients.
    Zang YN; Dong F; Li AN; Wang CY; Guo GX; Wang Q; Zhang YF; Zhang L; de Leon J; Ruan CJ
    Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):353-371. PubMed ID: 33677821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral olanzapine disposition in adolescents with schizophrenia or bipolar I disorder: a population pharmacokinetic model.
    Lobo ED; Robertson-Plouch C; Quinlan T; Hong Q; Bergstrom RF
    Paediatr Drugs; 2010 Jun; 12(3):201-11. PubMed ID: 20297865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly.
    Xiao T; Wang Z; Li G; Huang S; Zhu X; Liu S; Li X; Hu J; Shang D; Wen Y
    Drug Des Devel Ther; 2021; 15():3411-3423. PubMed ID: 34376974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients.
    Ji S; Shang D; Wu K; Li A; Li X; Deng C; Li L; Zhou T; Wang C; Lu W
    Int J Clin Pharmacol Ther; 2016 May; 54(5):378-89. PubMed ID: 27007997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed Conditions.
    Du P; Li P; Liu H; Zhao R; Zhao Z; Yu W; Zhou X; Liu L
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):621-628. PubMed ID: 31595704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study.
    Li AN; Dong F; He JL; Shang DW; Guo W; Li WB; Lu W; Wang CY
    Pharmacopsychiatry; 2015 Jul; 48(4-5):150-5. PubMed ID: 26079968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia.
    An H; Fan H; Chen S; Qi S; Ma B; Shi J; Wang Z; Yang F
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):255-259. PubMed ID: 33814547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level.
    Huang S; Li L; Wang Z; Xiao T; Li X; Liu S; Zhang M; Lu H; Wen Y; Shang D
    Drug Des Devel Ther; 2021; 15():3903-3913. PubMed ID: 34548782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and dosing optimization of olanzapine in Chinese paediatric patients: Based on the impact of sex and concomitant valproate on clearance.
    Xiao T; Hu JQ; Liu SJ; Lu HQ; Li XL; Kong W; Huang SQ; Zhu XQ; Zhang M; Lu HY; Ni XJ; Yang HL; Shang DW; Wen YG
    J Clin Pharm Ther; 2022 Nov; 47(11):1811-1819. PubMed ID: 36101489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects.
    Sun L; McDonnell D; Yu M; Kumar V; von Moltke L
    Clin Drug Investig; 2019 May; 39(5):477-484. PubMed ID: 30888624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking Subjects.
    Miroshnichenko II; Pozhidaev IV; Ivanova SA; Baymeeva NV
    Ther Drug Monit; 2020 Apr; 42(2):325-329. PubMed ID: 31425442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
    Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
    Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of olanzapine: Easy and reliable method for clinical correlation.
    Junutula SP; Dubasi SK; Reddy Padide SG; Miryala GK; Koppolu MS; Bandaru Sheshagiri SB; Eggadi V
    Indian J Pharmacol; 2021; 53(1):2-5. PubMed ID: 33975992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.
    Darby JK; Pasta DJ; Wilson MG; Herbert J
    Clin Drug Investig; 2008; 28(9):553-64. PubMed ID: 18666802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic/pharmacodynamic model of clozapine for characterizing the relationship between accumulated exposure and PANSS scores in patients with schizophrenia.
    Shang DW; Li LJ; Wang XP; Wen YG; Ren YP; Guo W; Li WB; Li L; Zhou TY; Lu W; Wang CY
    Ther Drug Monit; 2014 Jun; 36(3):378-86. PubMed ID: 24342896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.
    Polasek TM; Tucker GT; Sorich MJ; Wiese MD; Mohan T; Rostami-Hodjegan A; Korprasertthaworn P; Perera V; Rowland A
    Br J Clin Pharmacol; 2018 Mar; 84(3):462-476. PubMed ID: 29194718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative efficacy of three antipsychotic drugs for schizophrenia based on a real-world study in China.
    Zhang L; Li YG; He S; Zhang Y; Yu YM; Li Y; Wen H; Qiao Y; Shen YF; Li HF
    Acta Pharmacol Sin; 2019 Dec; 40(12):1611-1620. PubMed ID: 31388088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.